NOS2 and type 2 diabetes mellitus: From a mechanistic sight of view, EMPA reduced epigenetic changes induced by T2D, as it downregulated the activating epigenetic mark histone3 lysine4 trimethylation (H3K4me3) of the promoters of IFN-γ and iNOS.